Acanthaemoeba infection of the cornea is known to result in a wide spectrum of corneal disease requiring different management strategies. Prior to effective anti-amoebal Eye (1993) 7,719-725 therapy and early diagnosis, the organism was associated with devastating ocular damage, which still occurs in a small number of patients, influenced by various factors such as misdiagnosis,I-5 inappropriate antimicrobial treat ment, excessive topical steroid prior to correct diagnosis6.7 and resistant organisms.8.9 Acanthamoebae are good opportunists because of their ability to encyst, when they may become more resistant to the agents used.1O If the infection proceeds without appropriate early treatment, acanthamoebae appear to invade progressively deeper into the corneal stroma and are presumed to feed on keratocytes. Other tissues may be invaded, and acan thamoebae have even been isolated from the anterior chamber. II The success of topical agents may then be lim ited as their concentrations are reduced in these deeper tar get tissues; the importance of the role of currently available systemic anti-amoebal drugs is not yet clear.
The number of cases of Acanthamoeba keratitis pre senting per year in the United Kingdom appears to be rising, possibly because of increasing awareness of the condition and direct referral to specialist centres. In addi tion there has been a gradual rise in the number of dis posable lens wearers affected, 10 of 31 corneal culture-positive patients presenting between January 1989 and April 1992 wearing disposable lenses (A. S. Bacon et al., unpublished data, presented at the Oxford Congress of Ophthalmology 1992). The need for education and improved lens care practices has been identified, particu larly amongst the growing number of disposable lens wearers.
Ficker reported 11 cases of Acanthamoeba keratitis presenting at Moorfields Eye Hospital between 1986 and 1987. 12 We recently confirmed her finding that early treat ment using a combination of propamidine isethionate and neomycin is effective and associated with an excellent prognosis;6 15 consecutive patients diagnosed before 4 weeks from first symptoms regained 6/ 12 vision at least and only 1 with resistant disease required penetrating keratoplasty. The diagnosis of Acanthamoeba keratitis is high on the differential diagnosis list for atypical keratitis, especially in contact lens wearers, and therefore more patients are diagnosed early.
We now present updated findings on 72 patients (77 eyes) seen at Moorfields Eye Hospital between March 1984 and September 1992, in order to chart some of the changes in the pattern of presentation and diagnosis over these years. The primary aims are to establish prognostic factors in relation to the clinical features, the results of laboratory investigations and the outcome of medical and surgical management.
PATIENTS AND METHODS
A database of all patients diagnosed as having Acan thamoeba keratitis was kept prospectively from January 1990. Details from the case records of patients who had presented between 1984 and 1989 were added retrospec tively. At each outpatient visit clinical signs and treatment details were recorded.
The patients were divided into three groups on the basis of the interval between first symptoms and the introduc tion of anti-amoebal therapy, because the severity of disease and the final visual outcome appear related to this. 6 The groups were: 'early', those correctly diagnosed and starting treatment within a month (28 days) of first symp toms; 'intermediate', those starting appropriate treatment between 1 and 2 months after symptoms; and 'late', those presenting or being diagnosed after 2 months. Analysis of the presenting signs, clinical diagnosis, laboratory find ings, complications and outcome was performed.
Diagnostic Criteria
Forty-six of 72 patients (64%) had CUlture-positive cor neal tissue. A further 8 patients (11 %) had positive cul tures of Acanthamoeba from the contact lens, case or solutions in association with keratitis of presumed amoe bal aetiology. Of 18 further patients with presumed Acan thamoeba keratitis, 9 (13%) presented with perineural infiltrates (PNI), regarded as positive confirmation of the diagnosis (see Discussion). The last 9 (13%) were included on clinical grounds, having atypical keratitis in combination with typical symptoms and signs such as dis proportionate pain (n = 9), lens-wear (n = 9), ring infil trates (n = 3), dendriform ulceration (n = 3), limbitis (n = 9) and hypopyon (n = 2); they all exhibited a good clinical response to appropriate anti-amoebal therapy.
Diagnostic Procedure
A sheet of epithelium (epithelial biopsy) was removed from the affected cornea and divided in half. One speci men was placed in formol saline and sent for histopath ological analysis; the other was sent to the microbiology department. Microscopy was performed using calcofluor whiteI3 and immunostains.14 The specimen was partly homogenised and plated onto a non-nutrient agar plate which was then flooded with live Escherichia coli and the plates were incubated at 37°C for 72 hours. Acanthamoe bae were identified on binocular microscopy by the pres ence of trophozoites with vacuoles. If there was no growth at this stage the plates were incubated for a further 72 hours at 30°C, then if necessary at room temperature, and A. S. BACON ET AL.
were not finally discarded for 3 weeks. If there were stro mal infiltrates, scrapes from the advancing edge (off the visual axis where possible) were also taken. The contact lens, lens case and all available solutions were also sent for examination and culture. As a microbial screen, scrapes and biopsies were also plated onto blood agar for aerobic and reduced-oxygen culture, nutrient, thioglycollate and Robertson's cooked meat broths, Sabouraud and Lowen stein-Jensen media.
Formal corneal biopsy was performed if scrapes were negative in cases where the clinical response to treatment was poor. Biopsy samples and corneal discs from penetrating keratoplasties were examined by microscopy with the special stains and cultures described above.
Cultures of Acanthamoeba from all sources were sent to Mr. Simon Kilvington (Public Health Laboratory, Bath, UK) for storage and in vitro drug sensitivity testing in cases with a poor response to therapy.
Tr eatment
Combination anti-amoebal treatment was used. Propam idine and neomycin were the first line treatment until recently (1990-1), when the combination of propamidine isethionate and polyhexamethylene biguanide (PHMB)15 became more commonly used. Intensive treatment was commenced, with drops given at up to half-hourly inter vals and reduced as the clinical response began. When the eye was finally free of any clinical signs of inflammation or infection, one anti-amoebal (formerly propamidine but now often PHMB) was continued at a level of 2-4 times daily dose for 6-8 weeks. The regime was altered if there was a deterioration or no response, particularly if the in vitro tests confirmed resistance to the drugs used. Topical paromomycin 2.5%, clotrimazole 1 %, miconazole 1 % and oral itraconazole (100 mg once daily) and ketoconazole (200 mg once daily) were common agents added.
Oral flurbiprofen 50-100 mg two or three times daily was given for the treatment of pain and inflammation including limbitis and scleritis. Topical steroids (predniso lone 0.3% or dexamethasone 0.1 %) were reserved for eyes with specific indications such as uveitis, indolent ulcers, stromal lysis, or after keratoplasty; systemic steroids were reserved almost exclusively for scleritis, in combination with flurbiprofen and topical steroids.
The indications for penetrating keratoplasty changed over the years 1984-1992 as medical treatment showed success. Although reduction of the infective load was originally considered important, the current indications for keratoplasty in an inflamed eye are tectonic only. In a quite eye, however, keratoplasty may be done for optical reasons. patients (39%) were seen at Moorfields in the casualty department or the External Disease Service at their first presentation. Forty-four (6 1 %) were tertiary referrals from other centres: 12 from London and another 15 from the South East of England, 3 from the South West, 3 from the Midlands, 3 from the North East, 2 from the North West and 6 from abroad.
RESULTS

Source of Patients
Predisposing Factors
Sixty-four patients (89%) were contact lens wearers ( Fig. 1 ). The ratio of soft to rigid contact lenses of 2.7: 1 was actually lower than the 4: 1 worn by the population attending Moorfields 16 in a 1987-8 study. The number of patients who wore disposable lenses rose steadily from 1989 to 1992.
Diagnostic Delay
The interval between first symptoms and the diagnosis of Acanthamoeba keratitis (diagnostic interval) fell from 1985 (mean 180 days) to 1992 (mean 9.3 days) for those patients presenting directly to Moorfields (see Fig. 2 there was a similar proportion (16/2 1, 76%), although Acanthamoeba keratitis was the primary diagnosis in 3 cases (14%). In 1992, however, only 2 of 19 (11%) cases were misdiagnosed as herpes simplex keratitis and 9 of 19 (47%) were correctly diagnosed as Acanthamoeba keratitis.
Clinical Features
The presenting signs were markedly different in the early, intermediate and late groups (Fig. 3) , except that limbitis was almost universally present. Early disease was charac terised by limbitis, perineural infiltrates and superficial epithelial changes, with few ring infiltrates and little anterior uveitis. Patients in the later groups, however, demonstrated frank ulceration, ring infiltrates and anterior uveitis, often with hypopyon; a small number of patients demonstrated endothelial plaques causing corneal oedema. Perineural infiltrates were less common than in early disease. Further evolution of severe features of the disease, including ring ulcers, abscesses, hypopyon, scleritis, glau coma, cataracts and secondary microbial infection, occurred more commonly in later-presenting disease (Fig. 4) .
Rate of Culture-Positivity
A positive tissue diagnosis ofAcanthamoeba was made in 
Microbial Co-isolates
We found microbial co-isolates from corneal scrapes in 20 cases, both at presentation (14 cases) and on rescraping corneas with non-healing ulcers or new infiltrates (11 cases; Tables I, II) . The majority were in well-established disease. The organisms cultured were diverse and in 8 cases a mixed culture of more than two organisms was found. Five eyes gave positive cultures on both initial and later scrapes, separated by at least 6 months, and in 1 patient on treatment the same organisms were still viable in the corneal button taken after his eye perforated 4 months later. Deep corneal neovascularisation was found in 16 of 20 eyes with mixed infections, which was a significant increase compared with 8 of 57 with Acan thamoeba alone (X2 = 27.03, p<O.OOI; Yates' correc tion). The morbidity appeared prolonged in those with 
Medical Management
Propamidine and neomycin were most commonly used together (in 29 eyes). The combination of propamidine and PHMB was used alone in 13 eyes and all three drugs were used in another 12. Propamidine was used alone in 1 eye and a combination of between three and 12 drugs were used in the remaining 22 eyes including most commonly the above, paromomycin, itraconazole, clotrimazole, miconazole and ketoconazole. One patient also received acriflavine, poly myxin B, colistin, crystal violet, methyl benzalkonium chloride, an experimental drug (Rll/29) and brilliant green. Flurbiprofen was used in 42 of 72 cases, topical steroid in 49 of 77 eyes and systemic steroid was used in 4 of 72 cases, for the indications above (see Methods). Chronically non-healing ulcers, potentially due either to uncontrolled infection or to cessation of the healing pro cess, were reinvestigated with scrapes and cultures. In 3 eyes persistent Acanthamoeba was discovered and the anti-amoebal treatment was increased or changed. One also had a streptococcal superinfection, which was inten sively treated. Of a further 10 eyes with non-healing ulcers, 7 had intense punctate corneal or conjunctival stain and pain, and drop toxicity was thought to be an aggra vating factor; in 4 the ulcer was indolent with a necrotic surface. In 7 of these eyes propamidine and/or neomycin were reduced and given without preservatives or stopped; steroids were added in 6 eyes, botulinum toxin was used to give a therapeutic ptosis in 4 cases and debridement by lamellar keratectomy was performed in 2.
Recurrent amoebal corneal disease occurred in 8 eyes. In 3 of these treatment had been reduced to a low level (four times daily propamidine, 6 times daily PHMB and twice daily propamidine plus PHMB respectively) when new small infiltrates or satellites appeared; all recovered quickly on increased anti-amoebal drop frequency. In 1 complicated relapsing case a medical cure was achieved by adding PHMB, but the patient needed keratoplasty 3 months later when the eye was quiet. Four more severely affected eyes did not respond well to increased pro pamidine and neomycin (plus paromomycin in 1 and PHMB in 2) in spite of good in vitro sensitivities; 3 of them required 'hot' keratoplasty between 2 and 5 months later. The fourth developed glaucoma and cataract, and after cataract extraction first scleritis then finally phthisis ensued.
Patients received treatment as in-patients for a shorter time in 1992 than previously. Where hourly intensive initial therapy could not be given at home or there was severe sight-threatening disease, patients were admitted for treatment. The average total number of days as an in patient for patients diagnosed and successfully treated in 1992 was 2.4 days (n = 20); this compares with 59 days required for those diagnosed in 1987 (n = 9), gradually reducing to 9 days in 199 1 (n = 22).
Surgical Th erapy
Keratoplasty was performed in 1 of 36 eyes (3%) of the early-diagnosed cases, 6 of 17 eyes (35%) of the inter mediate group and 16 of 24 eyes (66%) of the late presenting groups. A total of 34 penetrating keratoplasties were done in 23 eyes.
Twenty-one procedures were performed in inflamed or 'hot' eyes (i.e. actively infected, perforated or with recur rence of infection in a graft) and 13 in uninflamed. Fig. 5 shows Kaplan-Meier survival curves for grafts in inflamed and uninflamed eyes, with probabilities of graft survival at 61 months being 0.35 and 0.69 respectively. The hazard ratio between the two was greatest at 12 months, at 7.34 (95% confidence interval 2.36-22.9).
Two of 13 'cold' procedures failed: 1 at 16 months due to uncontrolled glaucoma in a non-compliant individual and 1 at 30 months due to secondary bacterial endophthal mitis. The mean follow-up time for survival grafts in unin flamed eyes was 31 months (range 3-80 months). Failures occurred after 13 of 21 procedures in inflamed eyes, from 2 weeks post-operatively to 6 months (mean 12 weeks). The mean follow-up time of surviving grafts in inflamed eyes was 40 months (range 2-88 months); 2 of these patients were lost to follow-up abroad at 2 and 6 months post-operatively respectively. The commonest cause of graft failure was recurrent Acanthamoeba infection (9 eyes), usually within days; glaucoma caused failure in 3 and phthisis in 1. In these inflamed eyes, complications not resulting in failure included another Acanthamoeba recurrence and 3 more with glaucoma.
Keratoplasty was repeated once on 9 eyes. Four of these operations were successfully performed when the eye had become quiet, but of five 'hot' procedures, three failed. Two eyes underwent 'hot' second and third keratoplasties, utilising matched tissue in both cases for the latter, and only 1 of these survived.
Outcome
A medical cure was achieved in 63 of 73 eyes (86%) (out come data was only available in 73/77 eyes, since 4 were lost to follow-up abroad) and 13 of 63 quiet eyes went on to 'cold' keratoplasty for visual reasons. In a further 4 eyes, after a first failed keratoplasty, a medical cure was effected before regrafting was performed.
The visual outcome is broken down by group in Fig. 6 . Overall, of the 73 eyes, 58 (79%) have regained an acuity of between 6/4 and 6/ 12. A further 9 eyes (12%) have use ful vision of 6/ 18 to 6/60. One eye (l %) has vision of counting fingers, 1 (1 %) has light perception, and 4 (6%) have lost all perception of light.
The visual outcome was similar if the culture-positive cases are considered separately. Forty-six of the 73 eyes revealed Acanthamoeba on microscopy and/or culture of corneal specimens. Thirty-two of 46 (70%) achieved final visual acuities of 6/4 to 6/ 12, 9 (20%) achieved 6/ 18 to 6/60, 1 (2%) counting fingers, 1 (2%) light perception and 3 (6%) were left without perception of light.
The reasons for a poor final outcome were multifac torial and interrelated in the 15 eyes with a final acuity of 6/ 18 or less; they included late diagnosis (later than a month, n = 15), central scarring (n = 10), glaucoma (n = 5), resistant organisms (n = 2), microbial co infection (n = 7), prolonged steroid before the diagnosis of Acanthamoeba was made (n = 5), and failure of pen etrating keratoplasty (n = 7 eyes, 11 keratoplasties). The principal cause of profound visual loss was uncontrolled glaucoma, whereas the commonest cause of a loss of acuity down to 6/24 was axial corneal scarring. 
DISCUSSION
We believe that the biggest single variable still affecting the progress and outcome of the disease is the length of time between first symptoms and the institution of the anti-amoebal regime. We have established that the pre senting signs reflect generally deeper corneal involvement at presentation in later-presenting disease than in early disease. Clinical signs of severe disease including hypo pyon, glaucoma and cataract are uniformly more common in late-presenting disease. A higher proportion of cases require penetrating keratoplasty and the final visual acuity is commensurately poorer. Long-standing atypical kera titides still come to light, and in the last 2 years we have seen tertiary referrals up to 15 months after onset, our series including several late referrals from abroad. The laboratory staining, plating and culturing tech niques required for identifying Acanthamoeba necessitate expertise in a dedicated microbiological department. Con firmation of the diagnosis is particularly important to dis tinguish acanthamoebal from bacterial or fungal keratitis, since the treatment is so different, and every effort should be made to obtain corneal material, contact lenses and their care systems for culture. Eight patients in this series had negative corneal scrapes but with both a typical clinical picture and CUlture-positive lenses or solutions we consider these presumed amoebal, although we are aware that 0-7% of non-affected wearers may have Acan thamoeba culture-positive lens cases. 17 There is particu larly strong justification for the inclusion of cases with perineural infiltrates since there is only one report of these occurring in any other context, in Pseudomonas keratitis IX (and this may have been polymicrobial).
The number of corneas with microbial co-infection (20/ 27) was striking, although not as high as the 58% reported by M. S. Osato (unpublished data, presented at the American Academy of Ophthalmology 1992). The pres ence of bacterial keratitis in combined infections, both clinically and on culture, may delay the diagnosis of Acan thamoeba keratitis and therefore appropriate treatment. The question of whether the bacteria are the primary infecting agent is still largely speculative. Acanthamoeba thrive on bacterial colonies in culture, particularly on Gram-negative rods, and may reflect combined infection of the lenses or cases. 17, 19, 20 This sequence of events seems most likely where bacteria were isolated only days after the first symptoms were experienced. However, the cor neal ulceration seen in later-presenting acanthamoebal infection is a recognised risk factor for bacterial super infection. The majority of our cases support this latter mechanism for two reasons: the co-culture of fungus in I case and of more than one other bacterium in 8. Poly microbial infections tend to be more virulent and difficult to treat and are significantly associated with the develop ment of deep corneal neovascularisation (16/20 eyes with a mixed infection, vs. 8/57 with Acanthamoeba alone). Polymicrobial keratitis must be suspected if the features are atypical, there is a poor response to treatment or if new infiltrates appear. They should be investigated and treated aggressively, with intensive specific antibiotics.
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Recurrence of active disease in the cornea was noted in 1 case each of the earl y and intermediate groups and in 6 of the late-diagnosed group. In 3 of these it appeared that patients had simply reduced their treatment too quickly, and more intensive therapy allowed control to be regained. In I case surgery followed slow but successful medical control, but in another 4 cases satisfactory medical control was not achieved. The reasons for the apparent occasional resistance of Acanthamoeba to combinations of agents that have shown excellent in vitro activity9,15 are not clear; there is recent evidence that the clinical response may not reflect laboratory sensitivities. 21 The distinction between recurrent or persistent Acan thamoeba infection and non-infectious causes of failure to heal, such as drop toxicity or indolent ulcer, was critical since in the former the anti-amoebal treatment was inten sified and augmented whereas in the latter it was usually reduced and steroids added. Propamidine21 and neomycin are both potentially toxic to the corneal epithelium; numerous patients reported stinging or pain on using one or other of the drops, which in turn were reduced or sub stituted with other anti-amoebal agents such as PHMB. Preservatives in the drops were also identified as likely toxic agents after intensive multiple drug therapy, and unpreserved agents were substituted. Steroids were increased in 6 patients in the hope of reducing the lytic process at the surface, but botulinum-toxin-induced ptosis23 and debridement24.25 (by lamellar keratoplasty in our cases) were of most help in aiding re-epithelialisation in eyes with indolent ulcers.
Evaluation of the results of 34 keratoplasties is scarcely more encouraging than the earlier report by Ficker26 (16 patients being common to the two series), who indicated a probability of graft survival of 0.2 in inflamed eyes at 60 months. We have shown a probability of survival of 0.35 at 61 months in inflamed eyes. However, the outcome of graft ing uninflamed eyes was significantly better than inflamed, with a probability of survival at 61 months of 0.69, failure occurring late in only 2 of 13 uninflamed cases, I who defaulted on her glaucoma treatment and the other who developed a stitch infection followed by endophthalmitis. 01'2 1 procedures in inflamed eyes 13 failed; 9 of these were due to rapidly recurring Acanthamoeba infection, 3 failed due to glaucoma and 1 became phthisical. Elective surgery on a quiet eye at a later stage when limbitis has subsided reduces the risk of intractable post -keratoplasty glaucoma. The success of medical treatment (63/73 having undergone medical cure, whether or not grafting followed) has meant that unless there is a fulminant corneal abscess, perforation or heavy infection of a recent graft, surgery in the presence of active Acanthamoeba is contraindicated until a medical cure has been effected.
Culture-negative eyes were generally those which had been diagnosed early and were more superficially involved, which may therefore have had a smaller infecting (and cul turable) load. Other reasons for a negative culture may have included drying of the epithelial biopsy with rupture of trophozooites or infection by other organisms such as Valkampfid. 27 Cultures were not pursued where medical treatment induced a marked improvement, so that early cases rarely had multiple or formal corneal biopsies, per haps explaining their lower culture-positivity rate.
The final visual outcome was 6/ 12 or better in 58 of 73 eyes (79%) with presumed Acanthamoeba (data were available only for 73 of the 77 eyes originally diagnosed) and in 32 of 46 (70%) of those that were tissue culture positive. The outcome of those diagnosed before a month has been 6/ 12 or better in every case (Fig. 6) ; nevertheless the prospects for those diagnosed later have also improved so that the majority (2 1/33, or 64% of those diagnosed after a month) also achieve 6/ 12 or better. The 15 eyes with the poorest outcome were all diagnosed later than a month after first symptoms, and the commonest cause of profound visual loss was glaucoma.
The year 1992 may have been a milestone for Acan thamoeba keratitis in more than one way. Although more patients have presented to us almost every year since 1984, the number of non-lens-wearers, and wearers of non disposable soft and rigid lenses has changed little. Our index of suspicion of Acanthamoeba is higher than ever before, and wearers of disposable lenses are now most painstakingly investigated. The commonest initial clinical diagnosis has changed from herpes simplex to Acan thamoeba keratitis and the mean interval between first symptoms and institution of treatment has shortened every year, to its current 9.3 days. The use of PHMB in combi nation with other anti-amoebal agents, recently reported to be effective and relatively non-toxic, 15 has more con sistently confined the period of intensive treatment to a matter of weeks.2 1 Finally, early diagnosis has largely made it possible to avoid surgery in inflamed eyes and per sistence with medical therapy has allowed a primary medical cure in 63 of 73 eyes that were followed up. New patients presenting with Acanthamoeba keratitis may justifiably begin treatment with some optimism.
